Fierce Biotech Mix Logo.png Fierce Biotech Mix Logo.png
Webinar

Transitioning your drug from a vial to combination product

Available on-demand
60 Minutes
It is becoming increasingly common for pharma and biotech companies to have a clearly defined strategy to transition their drug from a vial into a combination product format to enhance patient experience as well as achieve favorable market positioning for their drug. However, with drug and device development following different tracks and not always matched up from a timeline standpoint, it is critical to align both pathways and ensure optimal integration by taking several vital considerations into account.
 
Join us for this webinar insightful webinar to learn the practical strategies that enable drug developers to manage this integration. We'll cover:
 
  • Selection of Prefilled Syringes 
  • Human Factor Studies 
  • Design Verification Testing 
  • Scalable Device Supply 
  • And More

Speakers

0

Lauren Orme

Lauren Orme has over 20 years of experience in pharmaceutical packaging, medical device and analytical services industries. Currently, Lauren leads the Regulatory Affairs Intelligence, Human Factors and Medical device labeling teams at West Pharmaceutical Services, Inc., Exton, PA. which ensures regulatory compliance by overseeing monitoring of, and compliance to, global regulatory requirements. Lauren earned a Bachelors of Science (B.S.) in Biology from West Chester University. She is certified as a Project Management Professional (PMP).

0

Meredith Canty

With more than 30 years of experience in the medical device and combination product industry, Meredith brings a blend of technical depth and commercial strategy to the field.  She spent her first 20 years of her career in engineering and program management, leading the development and launch of complex products from concept through commercialization.  Over the past decade, she has focused on strategic growth within contract manufacturing, helping organizations expand and scale their combination product capabilities.  Most recently, her work has centered on business development, partnering with pharmaceutical companies to bring innovative therapies to the market efficiently and reliably.

0

Matt Woods

Matt Woods started with West in 2019 as the extractables supervisor after serving as both an analyst and a supervisor for a CRO for 13 years.  Currently, Mr. Woods’ role is manager of the extractables and leachables group where he leads West’s team of 20 dedicated extractables and leachables scientists.  Mr. Woods’ focus is partnering with internal and external customers to design and execute extractables and leachables studies to satisfy both the customer’s needs as well as regulatory expectations.  Mr. Woods has extensive experience designing studies for a wide range of drug products and packaging systems including combination products and medical devices.  Mr. Woods has a bachelor’s degree in biochemistry and molecular biology from Lebanon Valley College.

Register here to watch on-demand!